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The Iowa Department of Public Health (IDPH) offers the Opioid Update to share information about opioid
use and Iowa’s efforts to address the national opioid epidemic. Please feel free to submit topics to RaChel
Greenwood at rachel.greenwood@idph.iowa.gov.
 





A State Opioid Response funded partnership between IDPH’s Bureau of Substance Abuse and the Board of
Pharmacy has made naloxone (the overdose reversal drug) available for free to Iowans at participating local
pharmacies since July 2020. As of August 2021, over 1,600 naloxone kits have been distributed throughout
Iowa, with higher uptake of the kits in some areas more than others (see below).
 
 
In July 2021, this partnership was expanded to also include drug disposal options. The new options allow
Iowans receiving an opioid prescription to also receive a free drug disposal packet to safely deactivate and
throw out any prescription medications. In just over one month, the program has distributed over 1,500
disposal kits. Several larger pharmacy chains are still working with MedOne, who administers the program,
to implement this new opportunity
 
Funding Opportunity for Providers of Medication Assisted Treatment and Recovery Support
Services
Through an award from the Substance Abuse and Mental Health Services Administration (SAMHSA), the
Iowa Department of Public Health (IDPH) expanded the State Opioid Response (SOR2) grant services in July
to community agencies and encourages interested agencies to apply. This funding allows agencies to be
more responsive in meeting the needs of individuals seeking services by providing a continuum of services






Supplemental Needs (clothing, hygiene items, wellness support, education, etc.)
Funding is intended to supplement existing services and funding streams and is not limited to substance
abuse treatment providers.
To learn more about this opportunity or to obtain an application, please visit the IDPH MAT Provider Website
at https://idph.iowa.gov/mat/provider. Applications to provide services will be accepted on an ongoing basis
based on service need and funding availability. Please direct any questions to SOR@idph.iowa.gov.
 
Narcan Kits Available for Interested Hospitals
The Iowa Department of Public Health (IDPH), in collaboration with the Iowa Hospital Association (IHA) and
the Iowa Healthcare Collaborative (IHC), are working to resolve the issue of opioid misuse in Iowa, including
preventing the deaths of Iowans struggling with an opioid use disorder.
As part of our ongoing Opioid Initiatives to prevent deaths involving opioids, IDPH, IHA and IHC are offering
free naloxone (Narcan nasal) kits to hospital emergency departments. The kits are to be distributed free of
charge to persons being released from the emergency department following an opioid overdose. In addition
to the Narcan kit, participating hospitals will be asked to distribute referral information provided by IDPH to
help connect individuals with local treatment services.
If your hospital would like to participate in this opportunity, please email EDnaloxone@ihconline.org and
share the following information: hospital (address), contact name, email, phone number and the number of
kits requested. One request per hospital will be accepted.
 
Opioid News
Opioid Tapering Carries Risks
Recently published results from a study reviewing medical and pharmacy claims as well as a large health
dataset from 2008 to 2019 challenges the assumption that opioid tapering unilaterally promotes patient
safety. The study included 113,618 patients in total and found that among patients prescribed stable, long-
term, higher-dose opioid therapy, tapering was significantly associated with increased risk of overdose and
mental health crisis.
As Dr. Agnoli told MedPageToday, "Our findings show increased risk of overdose and mental health crisis
following dose reduction, suggesting that patients undergoing tapering need significant support to safely
reduce or discontinue their opioids."
To read the article about the study, please click on this link: MedPage
To read the journal article, please click on this link: JAMA
 
DEA Expands Access to Mobile Narcotic Treatment Programs
Effective July 28, 2021, the U.S. Drug Enforcement Administration (DEA) lifted a 14-year moratorium on
methadone-dispensing vans operated by narcotic treatment programs (NTPs). Methadone is an evidence-
based medicine used to treat Opioid Use Disorder (OUD) as a medication-assisted treatment (MAT). Existing
methadone vans have been cost-effectively and successfully increasing access to this important medication. 
The DEA will no longer require providers to obtain a separate registration to operate a mobile component
and distribute controlled substances. It is anticipated that this action will lead to greater access to
Medication Assisted Therapy (MAT) for Opioid Use Disorder (OUD) in rural and underserved areas. 
To read an article detailing the DEA requirements, please click on the following link: NTP
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